Coccidioidomycosis complicating solid organ transplantation

Joy L. Logan, Janis E. Blair, John N. Galgiani

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations


Coccidioidomycosis is the most common endemic mycosis to cause disease in solid-organ transplant patients in North America. Underlying renal and liver disease, T-lymphocyte suppression from antirejection medication, and activation of immunomodulating viruses, such as cytomegalovirus, all increase the risk for coccidioidomycosis among these patients. About one half of all cases are the result of reactivation of previously acquired coccidioidal infection and occur during the first year after transplantation. Although disseminated infection is common, most cases manifest pulmonary symptoms. Culture of pulmonary secretions from bronchoscopy is frequently diagnostic. Serologic tests are particularly useful for identifying patients who are at high risk for reactivating coccidioidomycosis posttransplantation. Amphotericin B and azoles are the mainstay of therapy. Although there are no established approaches to preventing coccidioidomycosis among these patients, studies are underway examining the use of prophylactic azole antifungals with documented prior coccidioidal infection.

Original languageEnglish (US)
Pages (from-to)251-256
Number of pages6
JournalSeminars in Respiratory Infections
Issue number4
StatePublished - Dec 1 2001

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Microbiology (medical)


Dive into the research topics of 'Coccidioidomycosis complicating solid organ transplantation'. Together they form a unique fingerprint.

Cite this